New and Generic Drug Approvals
September 4, 2014
Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
---|---|---|---|---|
Antara (Micronized) | fenofibrate | Capsule;Oral | Lupin Atlantis | Manufacturing Change or Addition |
Aristocort | triamcinolone diacetate | Injectable;Injection | Sandoz | Manufacturing Change or Addition |
Aristospan | triamcinolone hexacetonide | Injectable;Injection | Sandoz | Manufacturing Change or Addition |
Atazanavir Sulfate;Ritonavir;Lamivudine; | atazanavir sulfate;ritonavir;lamivudine; | Tablet;Oral | Mylan Labs Ltd | Tentative Approval |
Betamethasone Dipropionate | betamethasone dipropionate | Cream;Topical | Fougera Pharms | Manufacturing Change or Addition |
Busulfex | busulfan | Injectable;Injection | Otsuka Pharm | Manufacturing Change or Addition |
Epaned Kit | enalapril maleate | For Solution;Oral | Silvergate Pharms | Efficacy Supplement with Clinical Data to Support |
Infuvite Adult | alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k | Injectable;Injection | Sandoz | Manufacturing Change or Addition |
Infuvite Adult | alpha-tocopherol acetate; ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a palmitate; vitamin k | Injectable;Iv (Infusion) | Sandoz | Manufacturing Change or Addition |
Infuvite Pediatric | ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine; riboflavin; thiamine; tocopherol acetate; vitamin a; vitamin k | Injectable;Iv (Infusion) | Sandoz | Manufacturing Change or Addition |
Infuvite Pediatric (Pharmacy Bulk Package) | ascorbic acid; biotin; cholecalciferol; cyanocobalamin; dexpanthenol; folic acid; niacinamide; pyridoxine; riboflavin; thiamine; tocopherol acetate; vitamin a; vitamin k | Injectable;Iv (Infusion) | Sandoz | Manufacturing Change or Addition |
Keytruda | pembrolizumab | Powder, For Injection Solution, Lyophilized Powder | Merck Sharp Dohme | Approval |
Lamivudine; Zidovudine; Efavirenz | lamivudine;zidovudine; | Tablet;Oral | Mylan Labs Ltd | Tentative Approval |
Latisse | bimatoprost | Solution/Drops;Topical | Allergan | Efficacy Supplement with Clinical Data to Support |
Latisse | bimatoprost | Solution/Drops;Topical | Allergan | Labeling Revision |
Metrogel | metronidazole | Gel;Topical | Galderma Labs Lp | Manufacturing Change or Addition |
Moxifloxacin Hydrochloride | moxifloxacin hydrochloride | Solution/Drops;Ophthalmic | Lupin Ltd | Approval |
Novolog | insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Flexpen | insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Flextouch | insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Innolet | insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Mix 50/50 | insulin aspart protamine recombinant; insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Mix 70/30 | insulin aspart protamine recombinant; insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Mix 70/30 Flexpen | insulin aspart protamine recombinant; insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Mix 70/30 Penfill | insulin aspart protamine recombinant; insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Novolog Penfill | insulin aspart recombinant | Injectable;Subcutaneous | Novo Nordisk Inc | Manufacturing Change or Addition |
Pradaxa | dabigatran etexilate mesylate | Capsule;Oral | Boehringer Ingelheim | Labeling Revision |
Zoledronic Acid | zoledronic acid | Injectable;Iv (Infusion) | Usv North America | Approval |
No comments:
Post a Comment